胺作为饮食障碍的辅助治疗:对一系列病例的探索性研究和回顾性分析
Paula J Escobedo-Aedo1, Chris Serrand2, Sarah Kabani2
1Department of Psychiatry, Torrejon University Hospital, Madrid, Spain.
Journal of eating disorders
|March 18, 2025
概括
胺辅助治疗 (KAT) 对厌食症神经障碍 (AN) 谱系障碍有希望,改善BMI并减少强迫性思想. 这种创新疗法可能为限制性饮食障碍患者提供新的希望.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 饮食障碍 (EDs),特别是神经性厌食症 (AN),严重影响身体和心理健康.
- 对于EDs,特别是AN,现有的治疗选择的有效性有限.
- 胺,一个NMDA对抗剂,显示出作为抑郁症和自杀念头的辅助治疗的潜力.
研究的目的:
- 探索胺辅助治疗 (KAT) 作为AN频谱的创新治疗方法的疗效.
- 研究KAT在解决严格的思维模式和限制性ED特征的神经认知偏见方面的潜力.
- 评估KAT对AN频谱障碍患者身体健康指标和精神病理学的影响.
主要方法:
- 八名被诊断患有AN谱系障碍的女性患者 (16-44岁) 的病例系列接受了静脉注射KAT与标准护理相结合.
- 该研究审查了现有的文献,讨论KAT在治疗EDs中的理论机制.
- 凯特会议包括心理运动和心理支持,以解决自我形象,身体感知,自尊和对食物的感官再接触.
主要成果:
- KAT显著改善了身体质量指数 (BMI),系数为0.71 (p=0.002),显示了从第四/第五次输液恢复体重的趋势.
- 用KAT治疗证明了AN精神病理和强迫症症状的减少,包括反,认知刚性和内.
- 在KAT干预后,整体临床演变显示改善.
结论:
- 胺辅助治疗 (KAT) 显示出作为限制性EDs的辅助治疗的显著潜力,特别是在一线治疗失败后.
- KAT有效地准了化的思维模式和神经认知偏见,这是AN的具有挑战性的方面.
- 氨酸的"亲塑性"和"亲神经发生"特性可能是其治疗效果的基础;需要进一步的受控研究.
相关概念视频
01:24Parenteral Anesthetics: Overview
91
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
91
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
145
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
145
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
138
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
138
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
170
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
170
01:30Electroconvulsive Therapy
21
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
21
01:23Binge Eating Disorders
45
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
45